No Picture
Boston Cambridge Biotech Trending News

Avilar Therapeutics Executives to be Featured Speakers on Advances in Protein Degradation at Upcoming Drug Discovery Conferences

WALTHAM, Mass.–(BUSINESS WIRE)–Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced that members of the company’s leadership team will be featured speakers on advances in the protein degradation field at two upcoming […]

No Picture
Boston Cambridge Biotech Trending News

UPDATED: Michel Vounatsos is on his way out as Biogen shutters Aduhelm effort and launches pipeline reorg

Stymied by Medicare and forced to admit the end of its once sky-high hopes in the controversial Alzheimer’s medicine Aduhelm, Biogen announced this morning that CEO Michel Vounatsos is being replaced as the big biotech […]

No Picture
News

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)– #Innosuisse–HAYA Therapeutics announces funding from Swiss Innovation Agency supporting research collaborations for Long Non-Coding RNA Therapies Click here to view original post